schizophrenia

Schizophrenia is a long-term mental health condition that causes a range of different psychological symptoms. These include: hallucinations (hearing or seeing things that do not exist), delusions (unusual beliefs that are not based on reality and often contradict the evidence), muddled thoughts based on the hallucinations or delusions, and changes in behaviour. Doctors describe schizophrenia as a psychotic illness. This means that sometimes a person may not be able to distinguish their own thoughts and ideas from reality.

Our schizophrenia Blogs

Psychotic symptoms are associated with poorer health: findings from WHO survey

No Responses »
Profile photo of Andre Tomlin
Posted by
globe

The WHO World Health Survey is a comprehensive international survey carried out across 70 countries, which uses face-to-face, telephone and online interviews to ask questions about the health of populations, public health risk factors, coverage and availability of health services and health care spending. The survey includes a number of questions relating to mental health [read the full story…]

Psychosis and schizophrenia in children and young people: NICE starts consultation

2 Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_1586899

The two month consultation period for the new NICE guideline on psychosis and schizophrenia in children and young people has now begun. You must be registered as a stakeholder to comment on the guideline and you have until 27th September 2012 to make your views known. The guideline is aimed at clinicians and service commissioners [read the full story…]

The risks of benzodiazepines, antidepressants and antipsychotics in adults with schizophrenia

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_71903914

Polypharmacy is the simultaneous use of two or more drugs to treat a single health condition. Polypharmacy is often used in the treatment of schizophrenia where people are regularly prescribed two or more antipsychotics, as well as antidepressants and/or benzodiazepines, although there is little evidence to prove that these combinations are more effective than monotherapy. [read the full story…]

Losing weight on antipsychotics. New systematic review looks at diet and exercise

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_85333330

Weight gain is one of the side effects that people who take antipsychotic drugs complain of the most. Obesity is common in this population and this can often lead to cardiovascular problems and a far shorter life expectancy than the rest of the population. As a result, there is a great deal of interest in [read the full story…]

Paliperidone palmitate injections for schizophrenia: new Cochrane systematic review

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_79355929

We know that people with schizophrenia who adhere to their treatment are more likely to experience sustained periods of time without psychotic symptoms. However, lots of patients find it hard to stick to the prescribed medication, so doctors sometimes recommend alternative treatments to try and encourage adherence. Long-acting intramuscular injections are one option available to [read the full story…]

Extrapyramidal side effects from second-generation antipsychotic drugs: new systematic review

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_45290365

The newer second-generation antipsychotic drugs (Risperidone, Quetiapine, Amisulpride, Aripiprazole, Clozapine, Olanzapine) are promoted because they have a lower risk of extrapyramidal side effects than older drugs. Drug companies often promote these newer drugs as virtually free from extrapyramidal side effects, but the patients who take them and the clinicians who prescribe them often don’t agree. [read the full story…]

Premature babies have greater risk of serious mental illness

6 Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_94550587

Preterm babies are three times more likely to be admitted to hospital for a mental health problem as an adult than normal term babies, according to a study published in the Archives of General Psychiatry by researchers in the UK and Sweden. About 1 in every 13 children born in the UK are classified as [read the full story…]

Mobile crisis teams reduce hospital admissions for serious mental illness, according to updated Cochrane review

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_58203940

‘Crisis intervention’ and ‘home-care packages’ are provided in the community to help people who are going through an acute phase of severe mental illness. The Cochrane Schizophrenia Group have updated their review on this topic by conducting their usual robust and systematic search for randomised controlled trials of crisis intervention models versus standard care for [read the full story…]

CBT is no better than other psychosocial therapies for people with schizophrenia, according to new Cochrane review

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_93283918

NICE guidance recommends offering CBT (cognitive behavioural therapy), family therapy and arts therapies for people with schizophrenia: Offer CBT to all people with schizophrenia. This can be started either during the acute phase or later, including in inpatient settings. – Taken from 1.3.4.1 in Schizophrenia (CG82). NICE, March 2009. However, CBT is still not widely [read the full story…]

Antipsychotic drugs reduce the rate of relapse in patients with schizophrenia at 1 year, according to new systematic review

No Responses »
Profile photo of Andre Tomlin
Posted by
shutterstock_73074289

There is an enormous body of research concerned with schizophrenia and the use of antipsychotic drugs. A quick search on PubMed for ‘schizophrenia, antipsychotics and randomised controlled trials’ brings back nearly 2,000 articles! The authors of a new systematic review and meta analysis published today in the Lancet, suggest that one area that has not [read the full story…]